Close Menu

NEW YORK – Horizon Discovery Group reported on Monday that its 2019 revenues rose nearly 8 percent year over year, thanks to growth in its research reagents and screening business units.

For the 12 months ended Dec. 31 2019, the gene editing and gene modulation technologies company reported total revenues of £58.3 million ($63.2 million), up from £54.1 million in 2018. On a constant currency basis, revenues rose nearly 5 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.